Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2026 04:00 ET | Source: AKAMPION

C-mo Medical Solutions Receives CE Mark for Its Novel AI-Powered Cough Monitoring Solution

CE-marked C-mo System combines a robust wearable biosensor, sophisticated AI-driven cough analysis and an intuitive digital platform.
April 15, 2026 02:30 ET | Source: Tensive

Tensive publishes positive interim pivotal clinical data showing REGENERA™ supports natural breast reconstruction in Updates in Surgery

Advanced biomaterial device designed for use in lumpectomy surgeries Interim results from the first 25 of 94 patients at 6 months follow upConfirms REGENERA™ is safe and biocompatible as breast tissue...
April 15, 2026 02:18 ET | Source: Clinuvel Pharmaceuticals Limited

CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026

MELBOURNE, Australia, April 15, 2026 (GLOBE NEWSWIRE) -- CLINUVEL’s innovative photomedicine and vitiligo programs featured extensively at the recent American Academy of Dermatology (AAD) Annual...
April 14, 2026 21:17 ET | Source: American Addiction Centers, Inc.

American Addiction Centers and Filmmaker Jeffrey Shulman Team Up to Promote Powerful New Film on Addiction and Recovery with National Theatrical Tour

American Addiction Centers and filmmaker Jeffrey Shulman are joining forces to bring national attention to “What It Takes,” a new documentary on recovery.
April 14, 2026 21:00 ET | Source: Shanghai EpimAb Biotherapeutics Co., Ltd.

EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting

SHANGHAI, April 15, 2026 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies and T-cell engagers, is pleased...
April 14, 2026 20:10 ET | Source: Mesoblast Limited

Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired...
April 14, 2026 19:04 ET | Source: Telix Pharmaceuticals Limited

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient has been dosed with...
April 14, 2026 17:40 ET | Source: Intermountain Health

Bruno Mars Presents $1 Million Gift to Intermountain Health for the Future Nevada Children’s Hospital

LAS VEGAS, April 14, 2026 (GLOBE NEWSWIRE) -- INTERMOUNTAIN NEWS RELEASE Link to Download Photos and B-Roll Video: https://lne.box.com/s/3xmd4yjhm8olepbj8d1amqsnkb7bh4s5 For Immediate...
April 14, 2026 15:17 ET | Source: Centre d’excellence sur la douleur chronique pour les vétérans canadiens

La table ronde nationale fait progresser les recherches sur la santé et la douleur chronique au Canada

GATINEAU, Québec, 14 avr. 2026 (GLOBE NEWSWIRE) -- Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens, en partenariat avec la Société canadienne de la douleur, a...
April 14, 2026 15:17 ET | Source: Chronic Pain Centre of Excellence for Canadian Veterans

National Roundtable Advances Women’s Health and Chronic Pain Research in Canada

GATINEAU, Quebec, April 14, 2026 (GLOBE NEWSWIRE) -- The Chronic Pain Centre of Excellence for Canadian Veterans, in partnership with the Canadian Pain Society, hosted a first-of-its-kind national...